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Gene Set Enrichment Analysis Made Simple
Rafael A. Irizarry∗, Chi Wang, Yun Zhou, Terence P. Speed∗
Abstract
Among the many applications of microarray technology, one of the most popular is the
identification of genes that are differentially expressed in two conditions. A common statistical
approach is to quantify the interest of each gene with a p-value, adjust these p-values for
multiple comparisons, chose an appropriate cut-off, and create a list of candidate genes. This
approach has been criticized for ignoring biological knowledge regarding how genes work
together. Recently a series of methods, that do incorporate biological knowledge, have been
proposed. However, many of these methods seem overly complicated. Furthermore, the most
popular method, Gene Set Enrichment Analysis (GSEA), is based on a statistical test known
for its lack of sensitivity. In this paper we compare the performance of a simple alternative to
GSEA. We find that this simple solution clearly outperforms GSEA. We demonstrate this with
eight different microarray datasets.
1 Introduction
The problem of identifying genes that are differentially expressed in two conditions has received
much attentions from the statistical community and data analysts in general. Most of the work has
focused on designing appropriate test statistics (Tusher, Tibshirani and Chu 2001, Smyth 2004) and
developing procedures to account for multiple comparisons (Storey and Tibshirani 2003, Dudoit,
Shaffer and Boldrick 2003). Most approaches follow a similar recipe: decide on a null hypothesis,
test this hypothesis for each gene, produce a p-value, and attach a significance level that accounts
for multiplicity. At the end, each gene receives a score which we use to decide if it is in our final
∗To whom correspondence should be addressed
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list of significant genes. Those on this final list are typically called candidate genes because further
validation tests are commonly performed. In this paper, we refer to this as the marginal approach.
A limitation of this approach is that genes that are known to be biologically associated are scored
independently. Although many important discoveries have been made with this approach, the
resulting gene lists do not always provide useful biological insights.
Recently, various approaches have been proposed to incorporate biological knowledge into the
analysis. The vast majority of these have relied on the results from the marginal approach instead
of starting from the original expression data. Because many of these marginal procedures have
been useful and given the complicated nature of microarray data we view this as a correct first
approach. In this paper we do not discuss nor propose methods that start from scratch.
There are currently two major types of procedure for incorporating biological knowledge into
differential expression analysis. We will refer to these as the over-representation and the aggregate
score approaches. In both, gene categories or gene sets are formed prior to the statistical analysis.
The sets are formed by, for example, grouping genes that are part of the same cellular components,
are essential for a biological process, or have the same molecular function. In many cases the
gene sets target the condition that is being studied. However, it is more common to use category
definitions from the Gene Ontology project (Lee, Braynen, Keshav and Pavlidis 2005). The Gene
Ontology project provides a controlled vocabulary to describe gene and gene product attributes in
any organism (The Gene Ontology Consortium 2000).
Over-representation analysis can be summarized as follows: First, form a list of candidate
genes using the marginal approach. Then, for each gene set, we create a two-by-two table compar-
ing the number of candidate genes that are members of the category to those that are not members.
The significance of over-representation can be assessed, for example, using the hypergeometric
distribution or its binomial approximation. More elaborate approaches exists and a large number
of over-representation methods have been published. Many of these have been implemented as
web-tools. A comprehensive list can be found at
http://www.geneontology.org/GO.tools.microarray.shtml.
A limitation of the over-representation approach is that it ignores all the genes that did not
make the list of candidate genes. Therefore, the results will be highly dependent on the cutoff used
in constructing this list. In fact, examples can be found where very few, or even none, of the genes
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in functional groups known to behave different in the two conditions survive the typical filters and
therefore the groups are not detected as interesting. Mootha, Lindgren, Eriksson, Subramanian, Si-
hag, Lehar, Puigserver, Carlsson, Ridderstra˚le, Laurila, Houstis, Daly, Patterson, Mesirov, Golub,
Tamayo, Spiegelman, Lander, Hirschhorn, Altshuler and Groop (2003) describes a particularly in-
teresting example. The aggregate score approach, does not have this limitation. The basic idea
is to assign scores to each gene set based on all the gene-specific scores for that gene set. There
are various ways to calculate these aggregate scores (Pavlidis, Lewis and Noble 2002, Pavlidis,
Qin, Arango, Mann and Sibille 2004, Mootha et al. 2003, Goeman, van de Geer, de Kort and van
Houwelingen 2004, Goeman, Oosting, Cleton-Jansen, Anninga and van Houwelingen 2005, Kim
and Volsky 2005, Subramanian, Tamayo, Mootha, Mukherjee, Ebert, Gillette, Pomeroy, Golub,
Lander and Mesirov 2005, Tian, Greenberg, Kong, Altschuler, Kohane and Park 2005). In this
paper we focus on the aggregate score method rather than the over-representation approach.
Of these methods GSEA (Mootha et al. 2003, Subramanian et al. 2005) is by far the most
popular. Surprisingly, GSEA is based on the Kolmogorov Smirnov (K-S) test which is well known
for its lack of sensitivity and limited practical use. Subramanian et al. (2005) seem to have realized
this and developed an ad-hoc modification of the K-S test. A further limitation of the K-S test and
its modified versions, is that the null distribution of the score is hard to compute. Tian et al. (2005)
proposed the use of the standard statistical approach for detecting shifts in center: a one sample
z-test. Tian et al. (2005) propose the use of permutation tests for assessing the significance of the
z-test. However, they do not explore the performance of the standard parametric approach. We
find that using the one sample t-test along with a standard multiple comparison adjustment (Storey
2002) of the normal distribution p-value works well in practice. This procedure is extremely simple
in comparison to GSEA and requires practically no computation time.
A possible advantage of GSEA, i.e. the K-S test, over the one sample z-test is that the latter
is specifically designed to identify gene sets with mean shifts and the K-S test is designed to find
general difference in the cumulative distribution. In principle, we want to be able to detect gene
sets for which some members are up-regulated and others are down-regulated. The z-test is not
sensitive to this change as there is no shift in mean. We therefore, propose the use of another
standard statistical test useful for detecting changes in scale: the χ2 test.
In this paper we compare GSEA to the one sample z-test and χ2-test using all the datasets
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described in Mootha et al. (2003) and Subramanian et al. (2005). In Section 2 we briefly describe
the methods in question. In Section 3 we present the results from the comparison. Finally, in
Section 4 we discuss these results describe some current work that we expect to improve upon our
proposed method and give concluding remarks.
2 Methods
Most aggregate score approaches start with the results from a marginal analysis. For example, we
may start with a t-statistic ti for each gene i = 1, . . . , N . We then identify gene set g with a subset
Ag ⊂ {1, . . . , N}. We want our score, say Eg (E for enrichment), to quantify how different the
ti, i ∈ Ag are from the ti, i 6∈ Ag. A second task is to assign a level of significance to each Eg.
Most methods take the approach of defining a null hypothesis, calculating the null distribution,
and assigning a level of significance. Because the score for dozens of gene sets are considered,
the significance levels are adjusted for multiple comparisons. The competing methods differ in the
way that different is quantified and the null hypothesis defined and calculated. Notice, that ti need
not be a t-statistic. In fact the GSEA paper uses another statistics that summarized the signal to
noise ratio for each gene. Because the resulting values are very similar to a t-statistic we refer to
the ti as signal to noise value and t-statistic interchangeably.
Mootha et al. (2003) used a version of the Kolmogorov-Smirnov (K-S) statistic to test for
differences in the distributions of the t-statistics related to members of a gene set compared to
t-statistics from the rest of the genes. Because they were interested in comparing these scores
across gene sets of different sizes, and then null distribution of the K-S statistic depends heavily
on this size, Mootha et al defined a normalized K-S statistics as their score EGSEA. To assess the
significance of these scores a permutation test was performed. Specially, they permuted the sample
labels and re-computed EGSEAg 1000 times. In each permutation the maximum enrichment score
was recorded. These 1000 values defined the null distribution and used to assign p-values. Mootha
et al. (2003) for details.
Subramanian et al. (2005) seem to have noticed the lack of power of the K-S test, a well-known
fact, and proposed an ad-hoc modification to improve this. Furthermore, in the original version of
GSEA, an adjusted p-value was calculated only for the enrichment score of the top ranking set. In
4
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Figure 1: Quantile-quantile plots. A) For the diabetes data presented in Mootha et al. we plot
the quantiles of the observed t-statistics versus the theoretical quantiles of the standard normal
distribution. The identity line is shown. B) For the same data we show the enrichment score based
on the z-test for the gene sets presented by Mootha et al. The score for the OXPHOS gene set is
high-lighted.
Subramanian et al. (2005), after normalizing the test statistic for each gene set, the FDR q-value
for each gene set was calculated and used to select candidate gene sets. The end results is a rather
complicated method that takes minutes to run on a typical laptop computer.
Determining if two sets of numbers have different distribution is certainly not a new problem.
Many solutions exist. The K-S test is one that has not been used in many (or any) other applica-
tions, so why use it here? Let us start with the most basic statistical approach: test for a shift in
center/mean as proposed by Tian et al 2005. If, under the null hypothesis, the ti are normally dis-
tributed with mean 0 and standard deviation 1, inference can be done with a one sample z-test. For
a robust version we could use a Wilcoxon test. When enough replicates are available in each con-
dition we expect the t-statistics to follow a standard normal distribution under the null-hypothesis
of no difference between the conditions. The data presented by Mootha et al seem to satisfy this
assumption. Figure 1A shows a quantile-quantile plot comparing the t-tests used in Mootha et
al. to a standard normal distribution. Figure 2 shows this quantile-quantile plot for all datasets
5
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Figure 2: As Figure 1 but for all the datasets presented in Mootha et al. 2003 and Subramanian et
al. 2005. The identity line is shown.
in Subramanian et al. (2005). Barring a few outliers, which are likely associated to differentially
expressed genes, the assumption appears appropriate in all datasets. If we assume that these tests
are independent (under the null) then for any given gene set the z-score:
Ezg =
√






with Ng the number of genes in Ag, also follows a standard normal distribution. This implies that
we can easily obtain a p-value.
With appropriate p-values calculated we have numerous multiple comparison adjustment meth-
ods to choose from and do not need to perform permutation tests. Tian et al argue that the normality
assumption is not appropriate because we expect the ti to be correlated even under the null hypoth-
esis. However, they do not appear to have tested this empirically. We find that assuming the Ezg are
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normally distributed under the null hypothesis is in fact a useful approximation for all the examples
we examined. For example, Figure 1B shows the z-score for the dataset presented in Mootha el
al. for the same gene sets they considered. Notice that the obvious outlier in Figure 1B, is the
OXPHOS gene set discovered to be important by Mootha et al. Thus, the discovery that merited
their publication would have been made with a statistical method that could be explained in one
paragraph instead of several pages.
A possible limitation of the one sample z-test is that it will not detect changes in scale. A
gene set where half the gene sets are up regulated and the other half are down regulated may have
no mean shift but is certainly interesting from a biological standpoint. The standard test for scale
change, i.e. the χ2-test, is useful for this. We define a standardized χ2-test that permits us to







2 − (Ng − 1)
2(Ng − 1)
. (2)
For gene sets that are large enough, say > 20, Eχ2g follows a standard normal distribution as
well. Thus computing p-values and adjusting these is just as straight forward as for the z-test.
3 Results
We computed the z-score and normalized χ2 for all gene sets and all datasets presented in Mootha
et al. (2003) and Subramanian et al. (2005). We used the latest version of GSEA. We adjusted for
multiple comparisons using Storey’s q-value (Storey 2002). We compared these to the q-values
computed using GSEA. Table 1 shows all the gene sets achieving a GSEA q-values of less than
0.25, as done by Subramanian et. al. With the exception of only three cases out of 4139, all gene
sets found by GSEA to have q-values < 0.025 were either in the top 10 gene sets or had a q-value
less than 0.05 for either the z-test or the χ2 test. The three cases are highlighted with bold letters
in Table 1. Notice that all three were found in the Michigan Lung Cancer dataset.
Figure 3 shows two gene sets: the GO ROS group in the Michigan Lung Cancer dataset and the
GLUT DOWN gene set in one of the Gender datasets. GO ROS would be considered interesting
in the Michigan Lung Cancer study by GSEA but not by the simpler methods. GLUT DOWN
would be considered interesting in the Gender data set by the z-test but not by GSEA. The only
7
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A) GO_ROS in Lung Cancer (Michigan) dataset













B) SNR verus A: GO_ROS






















C) GLUT_DOWN in Gender 2 dataset













D) SNR verus A: GLUT_DOWN











Figure 3: Gene sets showing disagreement between GSEA and the z-test. A) Empirical density
estimate of the the signal to noise values for the GO ROS group (dashed lines) and the rest of the
genes (solid line). The ticks on the x-axis show the actual observations. This particular group had
a small GSEA q-value but a z-test and χ2 > 0.25. B) For each gene, signal to noise values plotted
against the average intensity for the same dataset as in A). The values for the GO ROS gene set are
highlighted. Circles denote the up-regulated genes in the gene set and squares denote the down-
regulated genes. C) As A) but for the GLUT DOWN gene set in the Gender data set. The z-test
approach results in a very small q-value (< 0.001) for this gene set but a GSEA q-value larger than
0.25. D) As B) but for the data described in C).
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A) tob1Pathway in Lung Cancer (Michigan) dataset













B) SNR verus A: tob1Pathway






















C) ST_G_alpha_i_Pathway_ in Lung Cancer (Michigan) dataset













D) SNR verus A: ST_G_alpha_i_Pathway_











Figure 4: As Figure 3 but for the two other gene sets found by GSEA and not by the z-test or
χ2-test.
interesting feature of the GO ROS group is a gap (no observations of ti) between 0.5 and 1. We do
not consider this to be interesting enough to merit detection. On the other hand the GLUT DOWN
has a clear shift in mean. Figure 4 shows the other two gene sets found by GSEA and not by the
other methods. They do not appear interesting in any way.
Subramanian et al. (2005) pointed out that there is very little agreement in the results obtained
from the three lung cancer datasets they studied. They demonstrate the advantages of GSEA over
the marginal approach by showing better agreement between aggregate scores as compared to
marginal ones. We created lists of the top gene sets for these three studies using four different
approaches: the top 30 gene sets (lowest q-values) in each group as found by GSEA and the z-test,
all the gene sets with FDR < 0.25 for GSEA, and all the gene sets with FDR < 0.05 for the z-test.
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Table 1: For each of the eight datasets studies by Mootha et al. 2003 and Subramanian et al. 2005
we found the gene sets for which GSEA reports a q-value of 0.25 or less. Note that the Stanford
dataset had no gene sets passing this requirement. For the rest we show the q-values obtained for
these same gene sets when using the z-test and the χ2-test. The ranks of the gene sets obtained with
each of these three methods, within the dataset, are also shown. There are only three examples for
which the q-value was larger than 0.05 and the rank was larger than 10 in both the z-test and the
χ2- test. These are shown in bold.
GSEA z-test χ2 test
Study Gene set Size q-value Rank q-value Rank q-value Rank
Diabetes MAP00360 Phenylalanine metabolism 23 0.06 2 0.07 9 0.6 46
Diabetes MAP00910 Nitrogen metabolism 30 0.3 3 <0.01 6 0.6 43
Diabetes OXPHOS HG-U133A probes 114 0.04 1 <0.001 1 0.6 66
Gender 1 chrY 40 <0.001 1 <0.001 1.5 <0.001 2.5
Gender 1 chrYp11 18 <0.001 3 <0.001 3 <0.001 2.5
Gender 1 chrYq11 16 <0.001 2 <0.001 1.5 <0.001 2.5
Gender 2 XINACT MERGED 20 <0.001 1 <0.001 6 <0.001 2
Gender 2 GNF FEMALE GENES 85 0.05 3 <0.001 7 <0.001 2
Gender 2 TESTIS GENES 73 0.02 2 <0.001 2.5 <0.001 2
P53 rasPathway 22 0.2 6 <0.01 5 0.9 123
P53 p53hypoxiaPathway 20 <0.001 2 0.03 22 <0.001 1
P53 hsp27Pathway 15 <0.001 2 0.01 14 0.4 40
P53 p53Pathway 16 <0.001 2 <0.01 4 <0.001 2
P53 P53 UP 40 0.01 4 <0.001 2 <0.001 6
P53 radiation sensitivity 26 0.08 5 0.02 16 <0.001 3
Leukemia chr6q21 31 0.01 1 <0.001 2 0.8 23
Leukemia chr5q31 59 0.05 2 0.03 7 0.1 86
Leukemia chr13q14 31 0.06 3 0.2 16 0.4 7
Leukemia chr14q32 64 0.08 5 <0.01 3 <0.01 2
Leukemia chr17q23 39 0.07 4 <0.01 4 0.7 18
Boston p53hypoxiaPathway 19 0.05 1 <0.001 13 <0.01 18
Boston Aminoacyl tRNA biosynthesis 15 0.1 5 <0.001 12 0.2 63
Boston INSULIN 2F UP 113 0.1 2 <0.001 2.5 <0.01 22
Boston tRNA Synthetases 16 0.2 7 <0.001 9 0.3 91
Boston LEU DOWN 124 0.1 4 <0.001 2.5 <0.01 27
Boston HTERT UP 104 0.1 3 <0.001 5 0.05 38
Boston GLUT DOWN 199 0.2 6 <0.001 2.5 <0.001 8
Boston cell cycle checkpoint 19 0.2 8 <0.001 16 0.3 98
Michigan amiPathway 22 0.01 3.5 <0.001 6.5 1 208.5
Michigan cskPathway 22 0.01 3.5 <0.001 6.5 1 208.5
Michigan badPathway 19 <0.01 2 0.03 29 0.9 151
Michigan Il12Pathway 22 0.05 6 0.01 23 0.9 79
Michigan no2il12Pathway 16 0.08 7 0.02 25 1 246
Michigan GO ROS 18 0.09 8 0.06 54 0.9 156
Michigan tob1Pathway 18 0.2 17 0.06 53 0.9 69
Michigan HEMO TF LIST JP 66 0.2 13 <0.01 18 1 245
Michigan ctla4Pathway 16 0.2 20 <0.01 10 0.9 26
Michigan ST G alpha i Pathway 29 0.2 16 0.05 50 0.9 68
Michigan MAP00010 Glycolysis Gluconeogenesis 45 <0.01 1 <0.001 8 0.9 30
Michigan vegfPathway 21 0.03 5 <0.01 17 1 173
Michigan INSULIN 2F UP 113 0.2 9 <0.001 2 0.9 65
Michigan insulin signalling 77 0.2 10 0.04 39 0.9 8
Michigan HTERT UP 104 0.2 12 <0.001 5 0.3 4
Michigan MAP00251 Glutamate metabolism 18 0.2 14 0.01 21 0.9 19
Michigan ceramidePathway 18 0.2 15 <0.01 19 0.9 111
Michigan p53 signalling 65 0.2 11 <0.01 11 0.9 60
Michigan tRNA Synthetases 16 0.2 18 <0.01 14 0.9 55
Michigan MAP00970 Aminoacyl tRNA biosynthesis 15 0.2 19 <0.01 16 0.9 73
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Figure 5: Gene set agreement, shown with Venn diagram, in lung cancer dataset. The numbers in
the lower right corners are the number of gene sets that were not in any list. A) Agreement among
top 30 gene sets ranked by their GSEA q-value. B) As A) but for the z-test. C) Agreement among
gene sets achieving a GSEA q-value smaller than 0.25. D) As C) but for gene sets achieving a
q-value smaller than 0.05 with the z-test.
Figure 5 shows Venn diagrams for the results. It is clear that much better agreement is found with
the z-tests than with GSEA.
4 Discussion
We have compared GSEA to two very simple procedures based on standard statistical approaches:
the one sided z-test and the χ2 test. We found that the simpler methods outperformed GSEA in
assessments based on the eight datasets used in the GSEA papers and a simulation study. The
great majority of gene sets found by GSEA to be interesting are also found by the z-test. Notice
that if we expect gene sets to be interesting due to mean shifts then it is no surprise that the z-test
outperforms GSEA since statistical theory predicts this test to be much more powerful than the
K-S test. In fact, this is one reason we use the 0.05 cut-off, instead of 0.25, for the z-test q-value.
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An argument for GSEA could be that some gene sets are interesting for reasons other than mean
shifts, such as scale changes. For many of these cases the χ2 test was able to identify them as
interesting. The only three gene sets not found by either the z-test or χ2 test are shown in Table
1, Figure 3 and Figure 4. For all three it is hard to argue that they are interesting in anyway. We
notice that all three gene sets are small in size as compared to other gene sets and have unexpected
gaps in the observations of the signal to noise values. It is possible that the ad-hoc modification of
the K-S test is biased in favor of small gene sets.
Another advantage of the method presented here is that it can be easily extended to application
other than the comparison of two conditions. There is no need for the statistics used to compute
the enrichment scores described here, equation (1) and (2), to be t-statistics. Any statistics that
we expect to follow a standard normal distribution can be used. For example, another common
applications of microarrays examines cancer survival data. In these cases the summary statistics
is commonly a parameter estimate from a Survival model. The standard normal approximation
is a common approximation of the standardized versions of these estimates. Tian et al. (2005)
argue against the use of the normal approximation for the averaged t-tests and propose the use of
permutation-based tests. A disadvantage of their proposed permutation tests is that they are not
easily extended to cases other than comparison of two conditions. Tian et al. (2005) correctly point
out that if the t-statistics are correlated under the null hypothesis, the assumption that the z-score
is normal with standard deviation 1 is incorrect. We did not find this to be a problem in practice.
Furthermore, we find that the the average correlation in gene sets is of the order of 0.1 (data not
shown), which only corresponds to a 5% inflation of the score. A correction factor can easily be
inserted at the appropriate place.
An entirely parametric approach, as the one described here, has been previously proposed by
Kim and Volsky (2005). Their approach, referred to as PAGE, ignores the marginal t-tests, and
computes a t-test based on the effect sizes (log fold changes) within each gene set. A limitation of
this approach is that it does not take into account the gene-specific variances. This is problematic
because different genes are known to result in measurements with different variances (Kendziorski,
Irizarry, Chen, Haag and Gould 2005). Furthermore, PAGE is restricted to applications of compar-
ing two conditions. However, we expect PAGE to outperform GSEA as well.
We have made an argument against the use of GSEA. Methods that are much simpler, require
12
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hardly any computation time, and can be easily implemented in any data analysis package, have
been demonstrated to outperform GSEA. However, we do not think the methods we have described
here are a final solution. We describe them here because they are an obvious first step that has been
ignored. Efron and Tibshirani (2007) have proposed an approach that includes a statistic that
specifically targets gene sets with only a fraction of the genes differentially expressed and a novel
permutation approach. Falcon and Gentleman (2006) has developed methodology that takes into
account the fact that overlap exists between the different gene sets. These approaches certainly
seem promising.
13
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